Auburndale, FL, United States of America

J Christopher Flaherty

USPTO Granted Patents = 267 

 

 

Average Co-Inventor Count = 3.7

ph-index = 91

Forward Citations = 39,600(Granted Patents)

Forward Citations (Not Self Cited) = 38,952(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Bedford, MA (US) (1993)
  • Topsfield, CA (US) (2007 - 2012)
  • Topsfiled, MA (US) (2012)
  • San Clemente, CA (US) (2012)
  • Aurburndale, FL (US) (2017)
  • Los Altos, CA (US) (2000 - 2018)
  • Aburndale, FL (US) (2018)
  • Topsfield, MA (US) (1994 - 2021)
  • Middletown, RI (US) (2023)
  • Auburndale, FL (US) (2015 - 2024)
  • Nottingham, NH (US) (2024)
  • Taunton, MA (US) (2024)

Company Filing History:

goldMedal30 out of 974 
 
Medtronic Vascular, Inc.
 patents
silverMedal22 out of 35 
 
Transvascular, Inc.
 patents
bronzeMedal22 out of 30 
 
Rox Medical, Inc.
 patents
421 out of 91 
 
Medtronic Ablation Frontiers LLC
 patents
517 out of 190 
 
Insulet Corporation
 patents
614 out of 17 
 
Neograft Technologies, Inc.
 patents
714 out of 19 
 
Medrobotics Corporation
 patents
813 out of 28 
 
Acutus Medical, Inc.
 patents
913 out of 13 
 
Fractyl Laboratories, Inc.
 patents
1013 out of 22 
 
Fractyl Health, Inc.
 patents
1110 out of 10 
 
Braingate Co., LLC
 patents
129 out of 10 
 
Lumen Devices, LLC
 patents
137 out of 5,309 
 
Leland Stanford Junior University
 patents
146 out of 41 
 
Vertiflex, Inc.
 patents
156 out of 1,863 
 
University of Pittsburgh
 patents
165 out of 678 
 
Hologic, Inc.
 patents
174 out of 4 
 
Strato/infusaid, Inc.
 patents
184 out of 76 
 
Exactech, Inc.
 patents
194 out of 4 
 
Tissue Solutions, LLC
 patents
203 out of 54 
 
Circulite Gmbh
 patents
213 out of 12 
 
Functional Neuromodulation, Inc.
 patents
222 out of 14 
 
Strato Medical Corporation
 patents
232 out of 19 
 
Nalu Medical, Inc.
 patents
242 out of 1,651 
 
Edwards Lifesciences Corporation
 patents
252 out of 1,126 
 
Carnegie Mellon University
 patents
262 out of 14 
 
Xeltis Ag
 patents
272 out of 7 
 
Cryotherapeutics Gmbh
 patents
281 out of 1 
 
Programmable Pump Technologies, Inc.
 patent
291 out of 1 
 
Interlace Medical, Inc.
 patent
301 out of 15 
 
Ninepoint Medical, Inc.
 patents
311 out of 469 
 
Brown University
 patents
321 out of 4 
 
Shanghai Wallaby Medical Technologies Co., Inc.
 patents
331 out of 8 
 
Gentuity, LLC
 patents
341 out of 1 
 
Topsfield Medical Gmbh
 patent
351 out of 13 
 
Merlin Md Pte Ltd.
 patents
361 out of 1 
 
Phase2 Microtechnologies, Inc.
 patent
371 out of 4 
 
Cser Ventures, LLC
 patents
381 out of 7 
 
Orchid Sound Technologies LLC
 patents
391 out of 1,599 
 
Boston Scientific Neuromodulation Corporation
 patents
401 out of 3 
 
Kibur Medical, Inc.
 patents
411 out of 1 
 
Securus Medical Group, Inc.
 patent
425 out of 832,843 
Other
 patents
where one patent can have more than one assignee

Years Active: 1993-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Gastrointestinal Tract
Ablation Systems
Cardiac Analysis
Spinal Treatment
Bioerodible Wraps
Sleep Apnea Devices
Electrical Energy Ablation
Micro-Optic Probes
Injectate Delivery
Therapeutic Restrictions
Filamentous Tissue Implants
Artificial Arterio-Venous Fistula
267 patents (USPTO):Explore Patents

J. Christopher Flaherty is a well-known inventor with a knack for bringing innovative ideas to life. Based in Topsfield, MA, Flaherty has a whopping 233 patents to his name, making him a true pioneer in the field of inventions and patents.

His recent patents speak volumes about his ability to create groundbreaking, game-changing inventions that use state-of-the-art technology to change the world around us. One such patent is his Ultrasound sequencing system and method, which comprises a catheter configured for delivery to a body cavity defined by surrounding tissue, a plurality of ultrasound transducers coupled to a distal end of the catheter, and an electronics module configured to selectively turn on/off each ultrasound transducer according to a predetermined activation sequence. The system can process signals received from each ultrasound transducer to produce at least a 2D display of the surrounding tissue. A user can selectively calculate and display various aspects of cardiac activity. Moreover, the user can display Dipole Density (DDM), Charge Density (CDM), or Voltage (V-V). The shape and location of the chamber (surface), and the potentials recorded at electrodes can be displayed. The system can also change back and forth between the different display modes, and with post-processing tools, can change how various types of information is displayed.

Another one of Flaherty's patents is for methods, systems, and devices for reducing the luminal surface area of the gastrointestinal tract. These methods, systems, and devices for treating a patient include providing a tissue treatment element constructed and arranged to deliver energy to tissue and treating tissue of the gastrointestinal tract by causing the tissue treatment element to deliver energy to an energy delivery zone. Treatment results in a reduction in the luminal surface area of at least a portion of the gastrointestinal tract. In particular embodiments, the methods, systems and devices are used to treat diabetes.

Flaherty's contributions in the medical field have been nothing short of remarkable. He has worked for companies like ACUTUS MEDICAL, INC. and Fractyl Health, Inc., where he collaborated with talented individuals like Joshua Makower and Randell Louis Werneth.

It's clear that J. Christopher Flaherty has made a name for himself through his exceptional work in the field of inventions and patents. His contributions to the medical field have been truly remarkable. In fact, Flaherty's Ultrasound sequencing system and method and his methods, systems, and devices for reducing the luminal surface area of the gastrointestinal tract have the potential to revolutionize the medical industry as we know it.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…